Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial
Barbour, A.P., Walpole, E.T., Mai, G.T., Barnes, E.H., Watson, D.I., Ackland, S.P., Martin, J.M., Burge, M., Finch, R., Karapetis, C.S., Shannon, J., Nott, L.M., Varma, S., Marx, G., Falk, G.L., Gebski, V., Oostendorp, M., Wilson, K., Thomas, J., Lampe, G., Zalcberg, J.R., Simes, J., Smithers, B.M., Barbour, A., Simes, J., Walpole, E., Mai, T., Watson, D., Karapetis, C., Gebski, V., Barnes, L., Oostendorp, M., Wilson, K.
Published in Annals of oncology (01.02.2020)
Published in Annals of oncology (01.02.2020)
Get full text
Journal Article
Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel +/-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinoma
Barbour, A.P., Walpole, E.T., Mai, G.T., Barnes, L., Watson, D.I., Ackland, S.P., Wills, V., Martin, J., Burge, M., Karapetis, C.S., Shannon, J., Nott, L.M., Gebski, V., Oostendorp, M., Wilson, K., Thomas, J., Lampe, G., Zalcberg, J.R., Simes, J., Smithers, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
618PDProgression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel +/-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinoma
Barbour, A P, Walpole, E T, Mai, G T, Barnes, L, Watson, D I, Ackland, S P, Wills, V, Martin, J, Burge, M, Karapetis, C S, Shannon, J, Nott, L M, Gebski, V, Oostendorp, M, Wilson, K, Thomas, J, Lampe, G, Zalcberg, J R, Simes, J, Smithers, M
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article